High-resolution structures of the actomyosin-V complex in three nucleotide states provide insights into the force generation mechanism
Abstract
The molecular motor myosin undergoes a series of major structural transitions during its force-producing motor cycle. The underlying mechanism and its coupling to ATP hydrolysis and actin binding is only partially understood, mostly due to sparse structural data on actin-bound states of myosin. Here, we report 26 high-resolution cryo-EM structures of the actomyosin-V complex in the strong-ADP, rigor, and a previously unseen post-rigor transition state that binds the ATP analog AppNHp. The structures reveal a high flexibility of myosin in each state and provide valuable insights into the structural transitions of myosin-V upon ADP release and binding of AppNHp, as well as the actomyosin interface. In addition, they show how myosin is able to specifically alter the structure of F-actin.
Data availability
The atomic models and cryo-EM maps are available in the PDB (Burley et al., 2018) and EMDB databases (Lawson et al., 2011), under following accession numbers: aged PHD-stabilized actomyosin-V in the strong-ADP state: 7PM5, EMD-13521 (central 1er), 7PM6, EMD-13522 (central 3er/2er), 7PM7, EMD-13523 (class 2), 7PM8, EMD-13524 (class 3), 7PM9, EMD-13525 (class 4), 7PMA, EMD-13526 (class 5), 7PMB, EMD-13527 (class 6), 7PMC, EMD-13528 (class 7) ; aged PHD-stabilized actomyosin-V in the rigor state: 7PLT, EMD-13501 (central 1er), 7PLU, EMD-13502 (central 3er/2er), 7PLV, EMD-13503 (class 1), 7PLW, EMD-13504 (class 3) and 7PLX, EMD-13505 (class 4); aged PHD-stabilized actomyosin-V in the PRT state: 7PMD, EMD-13529 (central 1er), 7PME, EMD-13530 (central 3er/2er), 7PMF, EMD-13531 (class 1), 7PMG, EMD-13532 (class 3), 7PMH, EMD-13533 (class 4), 7PMI, EMD-13535 (class 5), 7PMJ, EMD-13536 (class 6), 7PML, EMD-13538 (class 8); young JASP-stabilized actomyosin-V in the rigor state: 7PLY, EMD-13506 (central 1er), 7PLZ, EMD-13507 (central 3er/2er), 7PM0, EMD-13508 (class 1), 7PM1, EMD-13509 (class 2), 7PM2, EMD-13510 (class 4); and young JASP-stabilized F-actin: 7PM3, EMD-13511. The datasets generated during the current study are available from the corresponding author upon reasonable request.
-
Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er)RCSB Protein Data Bank, 7PM5.
-
Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 3er/2er)RCSB Protein Data Bank, 7PM6.
-
Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er)RCSB Protein Data Bank, 7PLT.
-
Cryo-EM structure of the actomyosin-V complex in the rigor state (central 3er/2er)RCSB Protein Data Bank, 7PLU.
-
Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 1)RCSB Protein Data Bank, 7PLV.
-
Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 2)RCSB Protein Data Bank, 7PLW.
-
Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 4)RCSB Protein Data Bank, 7PLX.
-
Cryo-EM structure of young JASP-stabilized F-actin (central 3er)RCSB Protein Data Bank, 7PM3.
Article and author information
Author details
Funding
Max-Planck-Gesellschaft
- Stefan Raunser
European Commission (ERC-2019-SyG,856118)
- Stefan Raunser
Agence Nationale de la Recherche (ANR-17-CE11-0029-01)
- Anne Houdusse
National Institutes of Health (R01-DC009100)
- H Lee Sweeney
Centre National de la Recherche Scientifique
- Anne Houdusse
Studienstiftung des Deutschen Volkes
- Sabrina Pospich
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Samara L Reck-Peterson, University of California, San Diego, United States
Version history
- Preprint posted: September 7, 2021 (view preprint)
- Received: September 8, 2021
- Accepted: November 22, 2021
- Accepted Manuscript published: November 23, 2021 (version 1)
- Version of Record published: January 5, 2022 (version 2)
Copyright
© 2021, Pospich et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,360
- views
-
- 409
- downloads
-
- 30
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The articles in this special issue highlight how modern cellular, biochemical, biophysical and computational techniques are allowing deeper and more detailed studies of allosteric kinase regulation.
-
- Developmental Biology
- Structural Biology and Molecular Biophysics
The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.